Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Trans R Soc Trop Med Hyg ; 110(12): 690-695, 2016 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-28938053

RESUMEN

Background: Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had 'stopped-MDA' (after passing the transmission assessment survey) while 29 others remained with persistent microfilaraemia (mf) prevalence (≥1%) despite more than 11 years of MDA and were classified as 'hotspots'. Methods: An ecological study was carried out to compare baseline mf prevalence and anti-microfilaria interventions between hotspot and stopped-MDA districts. Results: Baseline mf prevalence was significantly higher in hotspots than stopped-MDA districts (p<0.001). After three years of MDA, there was a significant decrease in mf prevalence in hotspot districts, but it was still higher than in stopped-MDA districts. The number of MDA rounds was slightly higher in hotspot districts (p<0.001), but there were no differences in coverage of MDA or long-lasting-insecticide-treated nets. Conclusions: The main difference in hotspots and stopped-MDA districts was a high baseline mf prevalence. This finding indicates that the recommended 5-6 rounds annual treatment may not achieve interruption of transmission.


Asunto(s)
Filariasis Linfática/tratamiento farmacológico , Filariasis Linfática/epidemiología , Enfermedades Endémicas/prevención & control , Enfermedades Endémicas/estadística & datos numéricos , Filaricidas/administración & dosificación , Administración Masiva de Medicamentos/estadística & datos numéricos , Animales , Antígenos Helmínticos/inmunología , Transmisión de Enfermedad Infecciosa/prevención & control , Esquema de Medicación , Filariasis Linfática/prevención & control , Filariasis Linfática/transmisión , Filaricidas/farmacología , Filaricidas/uso terapéutico , Ghana/epidemiología , Investigación sobre Servicios de Salud , Humanos , Microfilarias/inmunología , Prevalencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA